Dynavax Technologies Corporation
USD15.50
+0.00 (+0.00%)
CEO
Ryan Spencer
IPO Date
2004-02-19
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$15.50
Prev. Close
$15.50
Day Low
$15.50
Day High
$15.50
52W Low
$9.20
52W High
$15.73
Market Cap
$1.82B
Volume
5.66M
| -281.7 |
| 31 Dec 2022 | FY | 63.7% | 40.6% | 50.5% | 29.7% | 0.44 | 6.11 | 4.6 |
| 31 Dec 2021 | FY | 60.5% | 17.5% | 34.5% | 7.4% | 1.16 | 1.75 | 21.3 |
| 31 Dec 2020 | FY | 70.1% | -161.6% | -128.2% | -21.3% | 3.71 | 3.75 | -6.0 |
| 31 Dec 2019 | FY | 44.9% | -433.3% | -1840.8% | -54.7% | 26.11 | 3.93 | -2.7 |
| 31 Dec 2018 | FY | -165.9% | -1938.3% | -252.0% | -75.3% | 1.60 | 4.33 | -3.6 |
| 31 Dec 2017 | FY | -265.1% | -29099.1% | -47.7% | -43.5% | 0.00 | 10.32 | -10.3 |
| 31 Dec 2016 | FY | 100.0% | -1018.2% | -126.1% | -102.5% | 0.00 | 4.06 | -1.4 |
| 31 Dec 2015 | FY | 100.0% | -2636.9% | -57.1% | -49.3% | 0.00 | 6.81 | -7.4 |
| 15.8 |
| 31 Mar 2025 | Q1 | 79.8% | -141.0% | -18.1% | -10.2% | 0.54 | 11.93 | -4.2 |
| 31 Dec 2024 | Q4 | 81.4% | 9.8% | 1.2% | 0.7% | 0.43 | 10.80 | 57.9 |
| 30 Sept 2024 | Q3 | 83.8% | 21.8% | 2.6% | 1.7% | 0.37 | 13.23 | 20.8 |
| 30 Jun 2024 | Q2 | 83.8% | 15.4% | 1.8% | 1.1% | 0.40 | 14.18 | 32.1 |
| 31 Mar 2024 | Q1 | 78.4% | -17.2% | -1.4% | -0.9% | 0.41 | 15.20 | -47.0 |
| 31 Dec 2023 | Q4 | 84.4% | 0.4% | 0.0% | 0.0% | 0.41 | 13.81 | 2064.8 |
| 30 Sept 2023 | Q3 | 81.0% | 20.6% | 2.4% | 1.5% | 0.43 | 15.40 | 33.3 |
| 30 Jun 2023 | Q2 | 77.5% | 5.7% | 0.6% | 0.4% | 0.45 | 17.78 | 121.1 |